Becton Dickinson (Becton Dickinson) Interest Expense : $-461 Mil (TTM As of Dec. 2023)

View and export this data going back to 1963. Start your Free Trial

What is Becton Dickinson Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Becton Dickinson's interest expense for the three months ended in Dec. 2023 was $ -111 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-461 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Becton Dickinson's Operating Income for the three months ended in Dec. 2023 was $ 513 Mil. Becton Dickinson's Interest Expense for the three months ended in Dec. 2023 was $ -111 Mil. Becton Dickinson's Interest Coverage for the quarter that ended in Dec. 2023 was 4.62. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Becton Dickinson Interest Expense Historical Data

The historical data trend for Becton Dickinson's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson Interest Expense Chart

Becton Dickinson Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Interest Expense

Get a 7-Day Free Trial

-639.00

-528.00

-469.00

-398.00

-452.00

Becton Dickinson Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-102.00	-118.00	-119.00	-113.00	-111.00

Becton Dickinson Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-461 Mil.

Becton Dickinson (NYSE:BDX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Becton Dickinson's Interest Expense for the three months ended in Dec. 2023 was $-111 Mil. Its Operating Income for the three months ended in Dec. 2023 was $513 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $14,094 Mil.

Becton Dickinson's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	513	/	-111
	=	4.62

The higher the ratio, the stronger the company's financial strength is.

Becton Dickinson (Becton Dickinson) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (NYSE:BDX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BDX:Mexico 1BDX:Italy BOX:Germany BOX:Germany BOX:Germany B1DX34:Brazil

Address

1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880

Website

https://www.bd.com

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Executives

Michael David Garrison	officer: EVP and President Medical	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Richard Byrd	officer: EVP & President Interventional	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Claire Fraser	director	C/O BECTON, DICKINSON AND COMPANY, FRANKLIN LAKES NJ 07465
David Hickey	officer: EVP & President, Life Sciences	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Joanne Waldstreicher	director	C/O STRUCTURE THERAPEUTICS INC., 611 GATEWAY BLVD, SUITE 223, SOUTH SAN FRANCISCO CA 94080
Michelle Quinn	officer: EVP and Acting General Counsel	1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Shan	officer: EVP, Integrated Supply Chain	1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Roland Goette	officer: EVP and President, EMEA	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher Delorefice	officer: EVP & CFO	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Polen Thomas E Jr	officer: Executive Vice President	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Samrat S. Khichi	officer: EVP and General Counsel	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Rishi Grover	officer: EVP and Chief ISC Officer	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Pavan Kumar Mocherla	officer: EVP and President Greater Asia	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
James C Lim	officer: Executive Vice President	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Thomas J Spoerel	officer: VP Controller & Chief Acct Off	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417